Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors-A proof of concept study

Peptides

Volumn 29, Issue 12, 2008, Pages 2188-2195

  Tammen, Harald ^a   Hess, Rüdiger ^a   Rose, Horst ^a   Wienen, Wolfgang ^b   Jost, Marco ^c  

^a Digilab BioVisioN GmbH   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

Author keywords

Dipetidylpeptidase IV; DPPIV; Factor Xa; FONDAPARINUX; Peptidomics; Protease inhibition

Indexed keywords

BLOOD CLOTTING FACTOR 10A; DIPEPTIDYL PEPTIDASE IV INHIBITOR; FONDAPARINUX; PROTEINASE; PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OUTCOME ASSESSMENT; PEPTIDE ANALYSIS; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINASE INHIBITION; RAT;

ANIMALS; ANTIGENS, CD26; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FACTOR X; MALE; PEPTIDES; PHOSPHONIC ACIDS; PROLINE; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

ANIMALIA;

EID: 56149103751     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.08.016     Document Type: Article

References (24)

1. Baggerman G., Verleyen P., Clynen E., Huybrechts J., De Loof A., Schoofs L., and Peptidomics. J Chromatogr B: Anal Technol Biomed Life Sci 803 (2004) 3-16
2. Balkan B., Kwasnik L., Miserendino R., Holst J.J., and Li X. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 42 (1999) 1324-1331
3. Belyaev A., Zhang X., Augustyns K., Lambeir A.M., De M., Vedernikova I., et al. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J Med Chem 42 (1999) 52-1041
4. Bristol J.A., Ratcliffe J.V., Roth D.A., Jacobs M.A., Furie B.C., and Furie B. Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation. Blood 88 (1996) 2585-2593
5. Burrell L.M., Johnston C.I., Tikellis C., and Cooper M.E. ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab 15 (2004) 166-169
6. Butenas S., and Mann K.G. Blood coagulation. Biochemistry (Mosc.) 67 (2002) 3-12
7. De Meester I., Lambeir A.M., Proost P., and Scharpe S. Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV. Adv Exp Med Biol 524 (2003) 3-17
8. Dobrovolsky A.B., and Titaeva E.V. The fibrinolysis system: regulation of activity and physiologic functions of its main components. Biochemistry (Mosc.) 67 (2002) 99-108
9. Gerotziafas G.T., Chakroun T., Samama M.M., and Elalamy I. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile. Thromb Haemost 92 (2004) 1296-1302
10. Gerotziafas G.T., Depasse F., Chakroun T., Van Dreden P., Samama M.M., and Elalamy I. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. Blood Coagul Fibrin 15 (2004) 149-156
11. Jost M.M. Surrogate end points: how well do they represent patient-relevant end points?. Biomarkers Med 1 (2007) 1-15
12. Koomen J.M., Li D., Xiao L.C., Liu T.C., Coombes K.R., Abbruzzese J., et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 4 (2005) 972-981
13. Lambeir A.M., Durinx C., Scharpe S., and De M. I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40 (2003) 209-294
14. Lamerz J., Selle H., Scapozza L., Crameri R., Schulz-Knappe P., Mohring T., et al. Correlation-associated peptide networks of human cerebrospinal fluid. Proteomics 5 (2005) 2789-2798
15. Menzel C., Guillou V., Kellmann M., Khamenya V., Juergens M., and Schulz-Knappe P. High-throughput biomarker discovery and identification by mass spectrometry. Comb Chem High Throughput Screening 8 (2005) 743-755
16. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 (2005) 3226-3245
17. Overall C.M., and Blobel C.P. In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8 (2007) 245-257
18. Rai A.J., Gelfand C.A., Haywood B.C., Warunek D.J., Yi J., Schuchard M.D., et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5 (2005) 3262-3277
19. Schluter H., Hildebrand D., Gallin C., Schulz A., Thiemann J., and Trusch M. Mass spectrometry for monitoring protease reactions. Anal Bioanal Chem 392 (2008) 783-792
20. Schroeder V., Vuissoz J.M., Caflisch A., and Kohler H.P. Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thromb Haemost 97 (2007) 890-898
21. Schulte I., Tammen H., Selle H., Zucht H.D., and Schulz-Knappe P. Clinical peptidomics: peptide-biomarker discovery in blood. In: Marko-Varga G. (Ed). Proteomics & Peptidomics (2005), Elsevier Science, Amsterdam
22. Tammen H., Schulte I., Hess R., Menzel C., Kellmann M., Mohring T., et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5 (2005) 3414-3422
23. Turpie A.G. Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy. Expert Opin Pharmacother 5 (2004) 1373-1384
24. Zucht H.D., Lamerz J., Khamenia V., Schiller C., Appel A., Tammen H., et al. Datamining methodology for LC-MALDI-MS based peptide profiling. Comb Chem High Throughput Screen 8 (2005) 717-723